Evidence map›Paper›PMID 23562159›Full record

ArticleImmunity2013

A network of high-mobility group box transcription factors programs innate interleukin-17 production.

Nidhi Malhotra, Kavitha Narayan, Ok Hyun Cho, Katelyn E Sylvia, Catherine Yin, Heather Melichar, Mehdi Rashighi, Veronique Lefebvre, John E Harris, Leslie J Berg and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 189 citations in OpenAlex.

  1. Article
  2. γδ T cells and cancer.The Journal of clinical investigation · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. HEB collaborates with TCR signaling to upregulatebioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nidhi MalhotraDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Kavitha Narayan
Ok Hyun Cho
Katelyn E Sylvia
Catherine Yin
Heather Melichar
Mehdi Rashighi
Veronique Lefebvre
John E Harris
Leslie J Berg
Joonsoo Kang
Immunological Genome Project Consortium
University of Massachusetts Chan Medical School · USCleveland Clinic Lerner College of Medicine · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
ImmGen: Gene Expression and Regulation in Immune CellsR24AI072073 · NIAID · JOSLIN DIABETES CENTER · PI CHRISTOPHE O. BENOIST · 2007 to 2026
$28.5M
Penn Dermatology Research Training ProgramT32AR007465 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice, David Joel Margolis · 1986 to 2026
$9.0M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Gene circuits programming IL-17 production in innate lymphocytesR01AI101301 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KANG, JOONSOO · 2013 to 2017
$2.1M
Plasticity of T helper cell differentiationR01AI101048 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BERG, LESLIE JOAN · 2013 to 2016
$1.6M
ROLES OF SOX C GENES IN SKELETOGENESISR01AR054153 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI LEFEBVRE, VERONIQUE M · 2006 to 2010
$1.6M
Regulation of conventional versus innate CD8+ T cell developmentR01AI084987 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BERG, LESLIE JOAN · 2010 to 2013
$1.6M
Regulation of T cell development by SOX13R01CA100382 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KANG, JOONSOO · 2005 to 2009
$1.5M
Targeting IFN gamma and chemokines to treat vitiligo in a humanized mouse modelK08AR061437 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HARRIS, JOHN E · 2011 to 2015
$619k
NCATS NIH HHS UL1 TR000439NCI NIH HHS CA100382NCI NIH HHS R01 CA100382NIAID NIH HHS AI072073NIAID NIH HHS AI084987NIAID NIH HHS R01 AI084987NIAID NIH HHS R01 AI101048NIAID NIH HHS R01 AI101301NIAID NIH HHS R24 AI072073NIAID NIH HHS T32 AI007349NIAMS NIH HHS AR54153NIAMS NIH HHS K08 AR061437NIAMS NIH HHS R01 AR054153NIAMS NIH HHS T32 AR007465NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

How innate lymphoid cells (ILCs) in the thymus and gut become specialized effectors is unclear. The prototypic innate-like γδ T cells (Tγδ17) are a major source of interleukin-17 (IL-17). We demonstrate that Tγδ17 cells are programmed by a gene regulatory network consisting of a quartet of high-mobility group (HMG) box transcription factors, SOX4, SOX13, TCF1, and LEF1, and not by conventional TCR signaling. SOX4 and SOX13 directly regulated the two requisite Tγδ17 cell-specific genes, Rorc and Blk, whereas TCF1 and LEF1 countered the SOX proteins and induced genes of alternate effector subsets. The T cell lineage specification factor TCF1 was also indispensable for the generation of IL-22 producing gut NKp46(+) ILCs and restrained cytokine production by lymphoid tissue inducer-like effectors. These results indicate that similar gene network architecture programs innate sources of IL-17, independent of anatomical origins.

Indexed as

AnimalsAntigens, LyAutoantigensCell DifferentiationCells, CulturedGene Regulatory NetworksHepatocyte Nuclear Factor 1-alphaHigh Mobility Group ProteinsImmunity, InnateInterleukin-17Interleukin-22InterleukinsIntestinesLymphocyte SubsetsLymphoid Enhancer-Binding Factor 1MiceAntigens, LyAutoantigensHepatocyte Nuclear Factor 1-alphaHigh Mobility Group ProteinsHnf1a protein, mouseInterleukin-17Interleukin-22InterleukinsLef1 protein, mouseLymphoid Enhancer-Binding Factor 1Natural Cytotoxicity Triggering Receptor 1Ncr1 protein, mouseNuclear Receptor Subfamily 1, Group F, Member 3Receptors, Antigen, T-Cell, gamma-deltaSox13 protein, mouseSox4 protein, mouseSOXC Transcription Factors

Identifiers

PMID23562159
PMCPMC3811080
OpenAlexW2109380034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.